Atlas Trials

Low Dose Treosulfan Based Conditioning Regimen in HSCT for Nijmegen Breakage Syndrome

Clinical trial NCT04400045 · UNKNOWN

Trial details

NCT number
NCT04400045
Sponsor
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Nijmegen Breakage Syndrome
Start date
2020-05-22
Primary completion
2023-05-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.